U.S. Analyst Updates: October 6th, 2026

Analyst Ratings (USA)

Today’s U.S. analyst updates suggest a selectively bullish but uneven outlook, with higher targets across semiconductors, AI infrastructure and selected software businesses. Financials remain mixed, as regional-bank upgrades contrast with target reductions across insurers, brokers and consumer lenders. Housing, automotive retail and transportation show greater caution through target cuts and some Sell initiations, while healthcare, defence, copper and refining attract selective support. Overall, analysts continue to favour specific growth opportunities while trimming expectations across several economically sensitive sectors.

Updates (364)

4D Molecular Therapeutics (FDMT) — Chardan Capital maintained its Buy rating and lowered its price target to $25.00 from $26.00.

AbbVie (ABBV) — Scotiabank maintained its Sector Outperform rating and raised its price target to $320.00 from $280.00.

AbbVie (ABBV) — UBS reiterated its Neutral rating.

Acadia Healthcare (ACHC) — Cantor Fitzgerald reiterated its Neutral rating.

Accenture (ACN) — Mizuho maintained its Outperform rating and raised its price target to $241.00 from $226.00.

Advance Auto Parts (AAP) — Evercore set a price target of $45.00; no rating was supplied.

Advanced Drainage Systems (WMS) — DA Davidson reiterated its Buy rating and a $190.00 price target.

Advanced Micro Devices (AMD) — Citigroup maintained its Buy rating and raised its price target to $800.00 from $575.00.

Advanced Micro Devices (AMD) — Mizuho maintained its Outperform rating and raised its price target to $705.00 from $580.00.

AeroVironment (AVAV) — Rothschild & Co Redburn initiated coverage with a Neutral rating and a $165.00 price target.

Affirm (AFRM) — TD Cowen maintained its Buy rating and lowered its price target to $110.00 from $124.00.

Aflac (AFL) — UBS maintained its Neutral rating and raised its price target to $125.00 from $124.00.

Albemarle (ALB) — BMO Capital Markets reiterated its Outperform rating and a $175.00 price target.

Alector (ALEC) — Morgan Stanley maintained its Underweight rating and raised its price target to $3.00 from $2.00.

Alector (ALEC) — UBS reiterated its Neutral rating and a $1.50 price target.

Alignment Healthcare (ALHC) — Barclays set a price target of $10.00; no rating was supplied.

Allegiant Travel (ALGT) — Citigroup reiterated its Buy rating.

Allstate (ALL) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $240.00 from $265.00.

Ally Financial (ALLY) — Goldman Sachs set a price target of $45.00; no rating was supplied.

Ally Financial (ALLY) — Raymond James maintained its Strong Buy rating and lowered its price target to $52.00 from $55.00.

Ally Financial (ALLY) — TD Cowen maintained its Buy rating and lowered its price target to $54.00 from $55.00.

Alphabet (GOOG) — UBS reiterated its Overweight rating.

Alphabet (GOOG/GOOGL) — Wells Fargo maintained its Overweight rating and raised its price target to $417.00 from $411.00.

Amazon.com (AMZN) — Susquehanna reiterated its Positive rating.

Amazon.com (AMZN) — Tigress Financial maintained its Buy rating and raised its price target to $385.00 from $315.00.

Amentum (AMTM) — BNP Paribas Exane upgraded its rating to Neutral from Underperform with a $20.00 price target (previous target: $21.00).

American Airlines Group (AAL) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $14.00 from $17.00.

American Express (AXP) — TD Cowen maintained its Hold rating and lowered its price target to $335.00 from $338.00.

American Integrity Insurance Group (AII) — Raymond James reiterated its Outperform rating.

American International Group (AIG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $80.00 from $81.00.

American International Group (AIG) — UBS maintained its Buy rating and raised its price target to $100.00 from $98.00.

Ameriprise Financial (AMP) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $520.00 from $560.00.

Amphenol (APH) — Goldman Sachs maintained its Buy rating and raised its price target to $116.00 from $102.00.

Anixa Biosciences (ANIX) — Citigroup reiterated its Buy rating.

Antero Resources (AR) — UBS maintained its Buy rating and lowered its price target to $54.00 from $58.00.

AON (AON) — Morgan Stanley maintained its Overweight rating and lowered its price target to $350.00 from $410.00.

Apple (AAPL) — UBS reiterated its Neutral rating.

AppLovin (APP) — Needham reiterated its Buy rating and a $475.00 price target.

Aptiv (APTV) — Goldman Sachs maintained its Buy rating and lowered its price target to $61.00 from $71.00.

ArcelorMittal (MT) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $64.00 from $69.00.

Arch Capital Group (ACGL) — Morgan Stanley maintained its Overweight rating and lowered its price target to $105.00 from $111.00.

Arthur J. Gallagher & Co. (AJG) — Morgan Stanley maintained its Overweight rating and lowered its price target to $260.00 from $285.00.

Asbury Automotive Group (ABG) — Barclays maintained its Equal Weight rating and lowered its price target to $230.00 from $265.00.

Assurant (AIZ) — Morgan Stanley maintained its Overweight rating and lowered its price target to $300.00 from $320.00.

Atmos Energy (ATO) — Argus reiterated its Buy rating and a $185.00 price target.

AutoNation (AN) — Barclays maintained its Overweight rating and lowered its price target to $230.00 from $260.00.

AvePoint (AVPT) — BMO Capital Markets initiated coverage with a Outperform rating and a $17.00 price target.

Banco Bradesco (BBD) — Bradesco Corretora upgraded its rating to Overweight from Neutral.

Banco De Chile (BCH) — JPMorgan Chase maintained its Neutral rating and lowered its price target to $44.00 from $45.00.

Banco Santander Chile (BSAC) — JPMorgan Chase maintained its Overweight rating and lowered its price target to $39.00 from $43.00.

Bank of America (BAC) — Rothschild & Co Redburn set a price target of $72.00; no rating was supplied.

BankUnited (BKU) — Raymond James maintained its Outperform rating and lowered its price target to $49.00 from $52.00.

Benitec Biopharma (BNTC) — Citigroup reiterated its Market Outperform rating.

Better Home & Finance (BETR) — Needham reiterated its Buy rating and a $25.00 price target.

BioRestorative Therapies (BRTX) — Maxim Group downgraded its rating to Hold from Buy.

BitMine Immersion Technologies (BMNR) — Cantor Fitzgerald reiterated its Overweight rating.

BlackRock (BLK) — JPMorgan Chase maintained its Overweight rating and raised its price target to $1,435.00 from $1,364.00.

Blaize (BZAI) — Craig Hallum downgraded its rating to Hold.

Booz Allen Hamilton (BAH) — TD Cowen maintained its Hold rating and raised its price target to $77.00 from $75.00.

BorgWarner (BWA) — Morgan Stanley upgraded its rating to Overweight from Equal Weight with a $95 price target.

Boston Beer (SAM) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $190.00 from $210.00.

Boyd Gaming (BYD) — Deutsche Bank upgraded its rating to Buy from Hold with a $99.00 price target (previous target: $98.00).

Bread Financial (BFH) — TD Cowen maintained its Hold rating and lowered its price target to $111.00 from $114.00.

BridgeBio Pharma (BBIO) — H.C. Wainwright reiterated its Buy rating.

Brown & Brown (BRO) — Morgan Stanley maintained its Underweight rating and lowered its price target to $55.00 from $60.00.

Builders FirstSource (BLDR) — Melius Research initiated coverage with a Sell rating and a $52.00 price target.

BWX Technologies (BWXT) — Truist Financial maintained its Hold rating and lowered its price target to $182.00 from $202.00.

C.H. Robinson Worldwide (CHRW) — Bank of America reiterated its Buy rating and a $203.00 price target.

C.H. Robinson Worldwide (CHRW) — Citigroup reiterated its Market Outperform rating.

C.H. Robinson Worldwide (CHRW) — Evercore set a price target of $217.00; no rating was supplied.

C.H. Robinson Worldwide (CHRW) — Jefferies reiterated its Buy rating and a $220.00 price target.

C.H. Robinson Worldwide (CHRW) — Sanford C. Bernstein reiterated its Market Perform rating.

C.H. Robinson Worldwide (CHRW) — TD Cowen reiterated its Hold rating.

C.H. Robinson Worldwide (CHRW) — UBS reiterated its Buy rating.

CACI International (CACI) — BNP Paribas Exane downgraded its rating to Underperform from Neutral with a $540.00 price target (previous target: $675.00).

Camping World (CWH) — JPMorgan Chase maintained its Overweight rating and lowered its price target to $9.00 from $11.00.

Capital One Financial (COF) — TD Cowen maintained its Buy rating and lowered its price target to $242.00 from $253.00.

CareTrust REIT (CTRE) — KeyCorp reiterated its Overweight rating.

CarGurus (CARG) — Barclays maintained its Overweight rating and lowered its price target to $38.00 from $41.00.

Carvana (CVNA) — Barclays maintained its Overweight rating and lowered its price target to $80.00 from $93.00.

Carvana (CVNA) — Stephens maintained its Overweight rating and lowered its price target to $83.00 from $91.50.

Celsius (CELH) — Jefferies reiterated its Buy rating and a $42.00 price target.

CGI Group (GIB) — RBC Capital Markets reiterated its Sector Perform rating and a $100.00 price target.

Chain Bridge Bancorp (CBNA) — Raymond James upgraded its rating to Outperform from Market Perform with a $53.00 price target.

Cheesecake Factory (CAKE) — Oppenheimer maintained its Outperform rating and raised its price target to $122.00 from $101.00.

Chord Energy (CHRD) — UBS maintained its Buy rating and raised its price target to $193.00 from $184.00.

Chubb (CB) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $350.00 from $360.00.

Cleveland-Cliffs (CLF) — Wells Fargo upgraded its rating to Overweight from Equal Weight with a $14.00 price target (previous target: $12.00).

Cloudflare (NET) — BTIG Research maintained its Buy rating and raised its price target to $413.00 from $382.00.

CMS Energy (CMS) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $73.00 from $77.00.

CMS Energy (CMS) — Capital One Financial set a price target of $73.00; no rating was supplied.

CMS Energy (CMS) — RBC Capital Markets set a price target of $73.00; no rating was supplied.

Commercial Metals (CMC) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $68.00 from $80.00.

Community Financial System (CBU) — Piper Sandler maintained its Neutral rating and lowered its price target to $65.00 from $71.00.

Compass Minerals International (CMP) — BMO Capital Markets reiterated its Market Perform rating.

Consolidated Edison (ED) — Jefferies reiterated its Hold rating and a $105.00 price target.

Corebridge Financial (CRBG) — UBS maintained its Neutral rating and raised its price target to $36.00 from $32.00.

Corteva (CTVA) — JPMorgan Chase upgraded its rating to Overweight from Neutral with a $19.00 price target.

CoStar Group (CSGP) — Needham reiterated its Buy rating and a $40.00 price target.

Credit Acceptance (CACC) — TD Cowen maintained its Hold rating and lowered its price target to $590.00 from $600.00.

Crescent Biopharma (CBIO) — H.C. Wainwright upgraded its rating to Buy from Neutral with a $36.00 price target.

D.R. Horton (DHI) — Barclays maintained its Equal Weight rating and lowered its price target to $130.00 from $141.00.

D.R. Horton (DHI) — Melius Research initiated coverage with a Sell rating and a $128.00 price target.

Dell Technologies (DELL) — Mizuho maintained its Outperform rating and raised its price target to $650.00 from $600.00.

Delta Air Lines (DAL) — UBS reiterated its Buy rating.

Delta Air Lines (DAL) — Wells Fargo maintained its Overweight rating and lowered its price target to $100.00 from $105.00.

Devon Energy (DVN) — BMO Capital Markets reiterated its Outperform rating and a $67.00 price target.

Diodes (DIOD) — Bank of America initiated coverage with a Buy rating and a $135.00 price target.

Diodes (DIOD) — Wells Fargo set a price target of $135.00; no rating was supplied.

Dollar General (DG) — Gordon Haskett upgraded its rating to Buy from Hold with a $140.00 price target.

DT Midstream (DTM) — Barclays maintained its Equal Weight rating and lowered its price target to $142.00 from $143.00.

Elmet Group (ELMT) — Canaccord Genuity Group maintained its Buy rating and raised its price target to $26.00 from $21.00.

Enphase Energy (ENPH) — Barclays set a price target of $44.00; no rating was supplied.

Envoy Medical (COCH) — Lake Street initiated coverage with a Buy rating and a $2.50 price target.

Equity Lifestyle Properties (ELS) — UBS maintained its Buy rating and lowered its price target to $67.00 from $76.00.

Ermenegildo Zegna (ZGN) — HSBC initiated coverage with a Buy rating and a $16.00 price target.

Expand Energy (EXE) — Mizuho maintained its Outperform rating and lowered its price target to $138.00 from $145.00.

Expedia Group (EXPE) — BTIG Research reiterated its Buy rating and a $400.00 price target.

Ferguson (FERG) — Melius Research initiated coverage with a Hold rating and a $252.00 price target.

Ferrovial (FER) — JPMorgan Chase downgraded its rating to Neutral from Overweight.

First Bancorp (FBNC) — Raymond James downgraded its rating to Outperform from Strong Buy with a $71.00 price target (previous target: $72.00).

First Merchants (FRME) — Raymond James upgraded its rating to Outperform from Market Perform with a $46.00 price target.

FirstCash (FCFS) — TD Cowen maintained its Buy rating and raised its price target to $242.00 from $240.00.

Flowers Foods (FLO) — Jefferies set a price target of $6.00; no rating was supplied.

Ford Motor (F) — Goldman Sachs maintained its Neutral rating and lowered its price target to $14.00 from $16.00.

Fortrea (FTRE) — Barclays upgraded its rating to Overweight from Equal Weight with a $23.00 price target (previous target: $22.00).

Fortune Brands Innovations (FBIN) — Barclays maintained its Equal Weight rating and lowered its price target to $47.00 from $54.00.

Fortune Brands Innovations (FBIN) — Melius Research initiated coverage with a Hold rating and a $44.00 price target.

Four Corners Property Trust (FCPT) — JPMorgan Chase maintained its Neutral rating and lowered its price target to $26.00 from $29.00.

Freeport-McMoRan (FCX) — Barclays maintained its Overweight rating and raised its price target to $83.00 from $82.00.

Freeport-McMoRan (FCX) — Wells Fargo maintained its Overweight rating and raised its price target to $87.00 from $70.00.

Fulton Financial (FULT) — Raymond James downgraded its rating to Market Perform from Outperform.

General Motors (GM) — Goldman Sachs maintained its Buy rating and raised its price target to $112.00 from $103.00.

Gentex (GNTX) — Goldman Sachs downgraded its rating to Sell from Neutral with a $20.00 price target (previous target: $23.00).

Geo Group (GEO) — JonesTrading reiterated its Buy rating and a $40.00 price target.

Geo Group (GEO) — UBS reiterated its Buy rating.

Globant (GLOB) — Mizuho maintained its Outperform rating and lowered its price target to $51.00 from $59.00.

The Goldman Sachs Group (GS) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $970.00 from $972.00.

Goosehead Insurance (GSHD) — Piper Sandler downgraded its rating to Neutral from Overweight with a $48.00 price target (previous target: $72.00).

Group 1 Automotive (GPI) — Barclays maintained its Overweight rating and lowered its price target to $320.00 from $365.00.

Gulfport Energy (GPOR) — UBS maintained its Buy rating and lowered its price target to $218.00 from $223.00.

Hallador Energy (HNRG) — Northland Securities set a price target of $27.00; no rating was supplied.

Hamilton Insurance Group (HG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $35.00 from $37.00.

The Hanover Insurance Group (THG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $230.00 from $240.00.

The Hartford Insurance Group (HIG) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $135.00 from $145.00.

The Hartford Insurance Group (HIG) — UBS maintained its Buy rating and lowered its price target to $149.00 from $155.00.

HeartBeam (BEAT) — H.C. Wainwright reiterated its Neutral rating.

Helen of Troy (HELE) — Canaccord Genuity Group maintained its Hold rating and raised its price target to $26.00 from $25.00.

Hilltop (HTH) — Raymond James downgraded its rating to Underperform from Market Perform.

Home Depot (HD) — Melius Research set a price target of $397.00; no rating was supplied.

Hormel Foods (HRL) — Piper Sandler reiterated its Neutral rating.

Hub Group (HUBG) — Wells Fargo maintained its Negative rating and lowered its price target to $28.00 from $35.00.

HubSpot (HUBS) — Needham reiterated its Buy rating and a $300.00 price target.

HubSpot (HUBS) — RBC Capital Markets reiterated its Outperform rating.

HubSpot (HUBS) — William Blair reiterated its Market Perform rating.

HudBay Minerals (HBM) — Barclays reiterated its Overweight rating.

Huntington Bancshares (HBAN) — Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to $18.00 from $19.50.

Huntington Bancshares (HBAN) — UBS set a price target of $18.00; no rating was supplied.

Huntsman (HUN) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $9.00 from $11.00.

Insmed (INSM) — BMO Capital Markets reiterated its Outperform rating.

Installed Building Products (IBP) — Melius Research initiated coverage with a Hold rating and a $217.00 price target.

Intel (INTC) — Mizuho maintained its Neutral rating and raised its price target to $114.00 from $92.00.

Intellia Therapeutics (NTLA) — Barclays initiated coverage with a Underweight rating and a $8.00 price target.

Interactive Brokers Group (IBKR) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $105.00 from $110.00.

Interactive Brokers Group (IBKR) — Capital One Financial set a price target of $105.00; no rating was supplied.

inTEST (INTT) — Northland Securities set a price target of $17.00; no rating was supplied.

iRhythm Technologies (IRTC) — Wells Fargo maintained its Overweight rating and lowered its price target to $150.00 from $168.00.

James Hardie Industries (JHX) — Melius Research initiated coverage with a Buy rating and a $36.00 price target.

James Hardie Industries (JHX) — Raymond James set a price target of $36.00; no rating was supplied.

JetBlue Airways (JBLU) — Citigroup upgraded its rating to Neutral from Sell with a $4.50 price target (previous target: $5.30).

Johnson & Johnson (JNJ) — RBC Capital Markets maintained its Outperform rating and raised its price target to $290.00 from $287.00.

JPMorgan Chase & Co. (JPM) — Barclays reiterated its Overweight rating.

KB Home (KBH) — Melius Research initiated coverage with a Sell rating and a $43.00 price target.

Keysight Technologies (KEYS) — Goldman Sachs maintained its Buy rating and raised its price target to $487.00 from $452.00.

Kinsale Capital Group (KNSL) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $350.00 from $390.00.

KLA (KLAC) — Morgan Stanley maintained its Overweight rating and lowered its price target to $227.00 from $253.00.

Klarna Group (KLAR) — TD Cowen maintained its Hold rating and lowered its price target to $16.00 from $18.00.

Knight-Swift Transportation (KNX) — Wells Fargo maintained its Overweight rating and lowered its price target to $81.00 from $86.00.

Korro Bio (KRRO) — H.C. Wainwright reiterated its Buy rating and a $15.00 price target.

Korro Bio (KRRO) — Jefferies set a price target of $15.00; no rating was supplied.

Kratos Defense & Security Solutions (KTOS) — Rothschild & Co Redburn initiated coverage with a Buy rating and a $70.00 price target.

Landstar System (LSTR) — Wells Fargo maintained its Overweight rating and lowered its price target to $225.00 from $240.00.

Lattice Semiconductor (LSCC) — William Blair initiated coverage with a Outperform rating.

Lazard (LAZ) — Capital One Financial set a price target of $38.00; no rating was supplied.

LB Pharmaceuticals (LBRX) — Guggenheim initiated coverage with a Buy rating and a $80 price target.

Lear (LEA) — Goldman Sachs maintained its Neutral rating and lowered its price target to $124.00 from $140.00.

Leidos (LDOS) — Jefferies reiterated its Hold rating and a $130.00 price target.

Leidos (LDOS) — TD Cowen maintained its Hold rating and lowered its price target to $130.00 from $135.00.

Lemonade (LMND) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $48.00 from $56.00.

Lennar (LEN) — Melius Research initiated coverage with a Sell rating and a $72.00 price target.

LGI Homes (LGIH) — Citigroup reiterated its Market Outperform rating.

Lincoln National (LNC) — UBS maintained its Neutral rating and raised its price target to $46.00 from $44.00.

Lithia Motors (LAD) — Barclays maintained its Overweight rating and lowered its price target to $375.00 from $415.00.

Lithium Americas (LAC) — BMO Capital Markets set a price target of $3.50; no rating was supplied.

Lockheed Martin (LMT) — Rothschild & Co Redburn initiated coverage with a Buy rating and a $650.00 price target.

Louisiana-Pacific (LPX) — Barclays maintained its Overweight rating and lowered its price target to $88.00 from $92.00.

Lowe’s Companies (LOW) — Evercore set a price target of $190.00; no rating was supplied.

Lowe’s Companies (LOW) — Melius Research set a price target of $244.00; no rating was supplied.

LPL Financial (LPLA) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $370.00 from $390.00.

LPL Financial (LPLA) — Capital One Financial set a price target of $370.00; no rating was supplied.

Lucid Group (LCID) — UBS reiterated its Hold rating.

LuxExperience B.V. (LUXE) — Sanford C. Bernstein initiated coverage with a Outperform rating and a $12.90 price target.

MapLight Therapeutics (MPLT) — Guggenheim initiated coverage with a Neutral rating.

Marsh & McLennan Companies (MRSH) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $180.00 from $200.00.

Marsh & McLennan Companies (MRSH) — UBS maintained its Buy rating and raised its price target to $222.00 from $216.00.

Masco (MAS) — Melius Research initiated coverage with a Hold rating and a $75.00 price target.

McDonald’s (MCD) — KeyCorp maintained its Overweight rating and lowered its price target to $280.00 from $305.00.

McKesson (MCK) — Morgan Stanley set a price target of $977.00; no rating was supplied.

MercadoLibre (MELI) — Susquehanna maintained its Positive rating and a $2,400.00 price target.

Meritage Homes (MTH) — Melius Research initiated coverage with a Sell rating and a $59.00 price target.

Meta Platforms (META) — Wells Fargo maintained its Overweight rating and raised its price target to $1,000.00 from $796.00.

MetLife (MET) — UBS maintained its Buy rating and raised its price target to $110.00 from $105.00.

Mobileye Global (MBLY) — Goldman Sachs maintained its Neutral rating and lowered its price target to $8.00 from $9.00.

Modine Manufacturing (MOD) — Robert W. Baird initiated coverage with a Outperform rating and a $300.00 price target.

Mohawk Industries (MHK) — Melius Research initiated coverage with a Buy rating and a $188.00 price target.

Morgan Stanley (MS) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $215.00 from $250.00.

MYR Group (MYRG) — Jefferies upgraded its rating to Buy from Hold with a $370.00 price target (previous target: $377.00).

Natera (NTRA) — Citigroup maintained its Buy rating and raised its price target to $480.00 from $365.00.

Nelnet (NNI) — TD Cowen maintained its Hold rating and lowered its price target to $125.00 from $130.00.

NeoGenomics (NEO) — BTIG Research upgraded its rating to Buy from Neutral with a $28 price target.

NeoGenomics (NEO) — Needham maintained its Buy rating and raised its price target to $22.00 from $19.00.

NetApp (NTAP) — TD Cowen maintained its Buy rating and raised its price target to $250.00 from $200.00.

Netflix (NFLX) — Goldman Sachs reiterated its Buy rating and a $90.00 price target.

Netskope (NTSK) — BTIG Research maintained its Buy rating and raised its price target to $22.00 from $18.00.

Neurocrine Biosciences (NBIX) — Guggenheim resumed coverage with a Buy rating and a $207.00 price target.

NextEra Energy (NEE) — Mizuho maintained its Neutral rating and lowered its price target to $80.00 from $95.00.

NIKE (NKE) — Berenberg downgraded its rating to Sell from Hold with a $27.50 price target.

Northern Trust (NTRS) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $190.00 from $208.00.

Northern Trust (NTRS) — Capital One Financial set a price target of $190.00; no rating was supplied.

Northrop Grumman (NOC) — Rothschild & Co Redburn initiated coverage with a Buy rating and a $680.00 price target.

NorthWestern (NWE) — Barclays maintained its Overweight rating and lowered its price target to $70.00 from $73.00.

Novartis (NVS) — Morgan Stanley reiterated its Overweight rating and a $156.00 price target.

OceanFirst Financial (OCFC) — Piper Sandler maintained its Neutral rating and lowered its price target to $18.00 from $21.00.

Old National Bancorp (ONB) — Raymond James upgraded its rating to Outperform from Market Perform with a $29.00 price target.

Old Second Bancorp (OSBC) — Raymond James upgraded its rating to Strong Buy from Outperform with a $30.00 price target (previous target: $27.00).

Omega Healthcare Investors (OHI) — Raymond James reiterated its Outperform rating and a $53.00 price target.

OMV (OMVKY) — RBC Capital Markets upgraded its rating to Sector Perform from Underperform.

OneMain (OMF) — TD Cowen maintained its Buy rating and lowered its price target to $66.00 from $68.00.

ONEOK (OKE) — JPMorgan Chase maintained its Neutral rating and lowered its price target to $100.00 from $106.00.

Option Care Health (OPCH) — Citigroup reiterated its Market Outperform rating.

Ovid Therapeutics (OVID) — Guggenheim initiated coverage with a Buy rating and a $7 price target.

Owens Corning (OC) — Barclays maintained its Overweight rating and lowered its price target to $162.00 from $177.00.

Owens Corning (OC) — Melius Research initiated coverage with a Sell rating and a $118.00 price target.

Pagaya Technologies (PGY) — TD Cowen maintained its Buy rating and lowered its price target to $25.00 from $26.00.

Parsons (PSN) — TD Cowen maintained its Buy rating and lowered its price target to $62.00 from $72.00.

PBF Energy (PBF) — Citigroup maintained its Neutral rating and raised its price target to $91.00 from $74.00.

PENN Entertainment (PENN) — Deutsche Bank upgraded its rating to Buy from Hold with a $25.00 price target (previous target: $23.00).

Penske Automotive Group (PAG) — Barclays maintained its Overweight rating and lowered its price target to $210.00 from $225.00.

PepsiCo (PEP) — RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $150.00 from $161.00.

Personalis (PSNL) — BTIG Research downgraded its rating to Neutral from Buy.

Personalis (PSNL) — UBS downgraded its rating to Neutral from Buy.

Pfizer (PFE) — Scotiabank set a price target of $33.00; no rating was supplied.

Pharvaris (PHVS) — H.C. Wainwright reiterated its Buy rating.

Pharvaris (PHVS) — UBS set a price target of $60.00; no rating was supplied.

PJT Partners (PJT) — BMO Capital Markets reiterated its Outperform rating.

PJT Partners (PJT) — Capital One Financial set a price target of $160.00; no rating was supplied.

Praxis Precision Medicines (PRAX) — BTIG Research maintained its Buy rating and raised its price target to $826.00 from $810.00.

Praxis Precision Medicines (PRAX) — H.C. Wainwright reiterated its Buy rating and a $1,201.00 price target.

Primis Financial (FRST) — Raymond James maintained its Strong Buy rating and lowered its price target to $18.00 from $19.00.

Procter & Gamble (PG) — Evercore upgraded its rating to Outperform from In-line with a $166.00 price target.

Procter & Gamble (PG) — RBC Capital Markets maintained its Outperform rating and lowered its price target to $166.00 from $167.00.

Prosperity Bancshares (PB) — Raymond James upgraded its rating to Outperform from Market Perform with a $78.00 price target.

PTC (PTC) — Citigroup maintained its Market Perform rating and raised its price target to $205.00 from $164.00.

PTC (PTC) — Mizuho maintained its Neutral rating and raised its price target to $205.00 from $160.00.

Pulse Biosciences (PLSE) — Canaccord Genuity Group maintained its Buy rating and raised its price target to $58.00 from $43.00.

PulteGroup (PHM) — Barclays maintained its Equal Weight rating and lowered its price target to $110.00 from $124.00.

PulteGroup (PHM) — Melius Research initiated coverage with a Hold rating and a $132.00 price target.

Qiagen (QGEN) — Barclays upgraded its rating to Overweight from Equal Weight with a $55 price target.

QXO (QXO) — Melius Research initiated coverage with a Buy rating and a $17.00 price target.

Rani Therapeutics (RANI) — H.C. Wainwright reiterated its Buy rating.

Rapport Therapeutics (RAPP) — Guggenheim initiated coverage with a Buy rating and a $65 price target.

Raymond James Financial (RJF) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $170.00 from $175.00.

RB Global (RBA) — Barclays maintained its Overweight rating and lowered its price target to $110.00 from $121.00.

Regeneron Pharmaceuticals (REGN) — JPMorgan Chase maintained its Overweight rating and raised its price target to $950.00 from $900.00.

Revvity (RVTY) — William Blair initiated coverage with a Outperform rating.

Rexel (RXEEY) — Morgan Stanley reiterated its Overweight rating.

Rezolute (RZLT) — Cantor Fitzgerald upgraded its rating to Overweight from Neutral.

Rezolute (RZLT) — Citigroup reiterated its Outperform rating.

Rezolute (RZLT) — Citizens Jmp maintained its Market Outperform rating and raised its price target to $15.00 from $11.00.

Rezolute (RZLT) — Lake Street reiterated its Buy rating and a $12.00 price target.

RH (RH) — TD Cowen reiterated its Buy rating.

Rio Tinto (RIO) — RBC Capital Markets upgraded its rating to Sector Perform from Underperform.

Rocket Companies (RKT) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $13.00 from $15.00.

Rumble (RUM) — Lake Street initiated coverage with a Hold rating and a $25.00 price target.

RXO (RXO) — BMO Capital Markets downgraded its rating to Market Perform from Outperform with a $30.25 price target.

RXO (RXO) — Citigroup maintained its Neutral rating and raised its price target to $30.00 from $23.00.

RXO (RXO) — Jefferies downgraded its rating to Hold from Buy with a $30.00 price target.

RXO (RXO) — JPMorgan Chase upgraded its rating to Neutral from Underweight with a $30.00 price target (previous target: $22.00).

RXO (RXO) — Wells Fargo maintained its Equal Weight rating and raised its price target to $30.00 from $23.00.

Ryan Specialty (RYAN) — Piper Sandler maintained its Neutral rating and lowered its price target to $40.00 from $48.00.

Sandisk (SNDK) — Mizuho maintained its Outperform rating and raised its price target to $2,050.00 from $1,875.00.

Schneider National (SNDR) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $35.00 from $38.00.

SentinelOne (S) — FBN Securities downgraded its rating to Sector Perform from Outperform with a $24.00 price target.

ServiceNow (NOW) — Citigroup reiterated its Market Outperform rating.

ServiceNow (NOW) — Stifel Nicolaus maintained its Buy rating and raised its price target to $160.00 from $120.00.

ServiceNow (NOW) — UBS maintained its Neutral rating and raised its price target to $150.00 from $110.00.

ServisFirst Bancshares (SFBS) — Raymond James downgraded its rating to Outperform from Strong Buy with a $45.00 price target (previous target: $50.00).

Sezzle (SEZL) — TD Cowen maintained its Buy rating and lowered its price target to $160.00 from $165.00.

Sherwin-Williams (SHW) — Melius Research initiated coverage with a Hold rating and a $367.00 price target.

Shift4 Payments (FOUR) — B. Riley Securities maintained its Buy rating and lowered its price target to $94.00 from $96.00.

Shopify (SHOP) — JPMorgan Chase maintained its Overweight rating and raised its price target to $200.00 from $185.00.

Skyworks Solutions (SWKS) — B. Riley Securities upgraded its rating to Buy from Neutral with a $107.00 price target (previous target: $68.00).

Skyworks Solutions (SWKS) — Citigroup maintained its Neutral rating and raised its price target to $90.00 from $64.00.

Snap-On (SNA) — Barclays set a price target of $435.00; no rating was supplied.

SoFi Technologies (SOFI) — TD Cowen maintained its Hold rating and lowered its price target to $17.50 from $18.00.

Sol-Gel Technologies (SLGL) — H.C. Wainwright reiterated its Buy rating.

Sonic Automotive (SAH) — Barclays maintained its Equal Weight rating and lowered its price target to $75.00 from $87.00.

Southern Copper (SCCO) — Wells Fargo maintained its Equal Weight rating and raised its price target to $190.00 from $172.00.

Sphere Entertainment (SPHR) — BTIG Research maintained its Buy rating and lowered its price target to $160.00 from $190.00.

Sphere Entertainment (SPHR) — Citigroup reiterated its Market Outperform rating.

Sphere Entertainment (SPHR) — Wells Fargo set a price target of $200.00; no rating was supplied.

Sprouts Farmers Market (SFM) — JPMorgan Chase maintained its Overweight rating and lowered its price target to $90.00 from $103.00.

SPX Technologies (SPXC) — Robert W. Baird initiated coverage with a Outperform rating and a $220 price target.

Standard Nuclear (STDN) — CLSA upgraded its rating to Neutral.

Standard Nuclear (STDN) — Needham initiated coverage with a Buy rating and a $18.00 price target.

Stanley Black & Decker (SWK) — Morgan Stanley set a price target of $100.00; no rating was supplied.

State Street (STT) — BMO Capital Markets maintained its Outperform rating and lowered its price target to $200.00 from $212.00.

State Street (STT) — Capital One Financial set a price target of $200.00; no rating was supplied.

State Street (STT) — Truist Financial maintained its Hold rating and lowered its price target to $190.00 from $191.00.

Stifel Financial (SF) — BMO Capital Markets maintained its Market Perform rating and lowered its price target to $75.00 from $85.00.

Stifel Financial (SF) — Capital One Financial set a price target of $75.00; no rating was supplied.

Stifel Financial (SF) — JPMorgan Chase maintained its Neutral rating and lowered its price target to $82.00 from $86.00.

Stryker (SYK) — Truist Financial set a price target of $310.00; no rating was supplied.

Sun Communities (SUI) — UBS maintained its Neutral rating and lowered its price target to $117.00 from $133.00.

Super Micro Computer (SMCI) — Mizuho maintained its Neutral rating and raised its price target to $43.00 from $35.00.

Synchrony Financial (SYF) — TD Cowen maintained its Buy rating and lowered its price target to $86.00 from $90.00.

Taiwan Semiconductor Manufacturing (TSM) — Barclays maintained its Overweight rating and raised its price target to $665.00 from $650.00.

TE Connectivity (TEL) — Goldman Sachs maintained its Buy rating and raised its price target to $288.00 from $284.00.

Ternium (TX) — Wells Fargo maintained its Equal Weight rating and raised its price target to $56.00 from $52.00.

Texas Capital Bancshares (TCBI) — Raymond James maintained its Outperform rating and lowered its price target to $108.00 from $115.00.

Toll Brothers (TOL) — Barclays maintained its Underweight rating and lowered its price target to $118.00 from $122.00.

Toll Brothers (TOL) — Melius Research initiated coverage with a Buy rating and a $179.00 price target.

Trex (TREX) — Melius Research initiated coverage with a Buy rating and a $62.00 price target.

Tyra Biosciences (TYRA) — Raymond James reiterated its Strong Buy rating and a $50.00 price target.

U.S. Bancorp (USB) — Raymond James maintained its Strong Buy rating and lowered its price target to $72.00 from $74.00.

United Airlines (UAL) — Wells Fargo maintained its Overweight rating and lowered its price target to $160.00 from $165.00.

Upbound Group (UPBD) — TD Cowen maintained its Buy rating and lowered its price target to $27.00 from $28.00.

Upstart (UPST) — Needham reiterated its Buy rating and a $42.00 price target.

Valero Energy (VLO) — Barclays maintained its Overweight rating and raised its price target to $441.00 from $323.00.

Valero Energy (VLO) — UBS reiterated its Buy rating and a $467.00 price target.

Valley National Bancorp (VLY) — Keefe, Bruyette & Woods maintained its Market Perform rating and raised its price target to $17.00 from $16.00.

Valvoline (VVV) — Barclays maintained its Equal Weight rating and lowered its price target to $39.00 from $41.00.

Versigent (VGNT) — Goldman Sachs maintained its Buy rating and lowered its price target to $58.00 from $59.00.

Vertiv (VRT) — Glj Research initiated coverage with a Sell rating and a $188.00 price target.

Veru (VERU) — Westpark Capital initiated coverage with a Buy rating.

Visteon (VC) — Goldman Sachs maintained its Buy rating and lowered its price target to $104.00 from $126.00.

Voya Financial (VOYA) — UBS maintained its Buy rating and raised its price target to $127.00 from $125.00.

Vylor (VYLR) — Oppenheimer initiated coverage with a Outperform rating and a $82 price target.

W.R. Berkley (WRB) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $70.00 from $75.00.

Walt Disney (DIS) — Sanford C. Bernstein reiterated its Outperform rating.

Wartsila (WRTBY) — Goldman Sachs upgraded its rating to Buy from Neutral.

Werner Enterprises (WERN) — Wells Fargo maintained its Equal Weight rating and lowered its price target to $37.00 from $46.00.

WesBanco (WSBC) — Piper Sandler maintained its Neutral rating and lowered its price target to $45.00 from $46.00.

WesBanco (WSBC) — Raymond James downgraded its rating to Market Perform from Strong Buy.

Willis Towers Watson Public (WTW) — Morgan Stanley maintained its Equal Weight rating and lowered its price target to $310.00 from $350.00.

Willis Towers Watson Public (WTW) — UBS maintained its Buy rating and lowered its price target to $398.00 from $405.00.

Workday (WDAY) — Citigroup reiterated its Neutral rating.

Worthington Steel (WS) — KeyCorp reiterated its Overweight rating.

Xenon Pharmaceuticals (XENE) — Guggenheim resumed coverage with a Buy rating and a $73.00 price target.

Xeris Biopharma (XERS) — Barclays maintained its Overweight rating and raised its price target to $14.00 from $12.00.

XP (XP) — Itau BBA upgraded its rating to Outperform from Market Perform with a $27 price target.

Yum! Brands (YUM) — Guggenheim maintained its Buy rating and lowered its price target to $155.00 from $180.00.

Zai Lab (ZLAB) — Cantor Fitzgerald reiterated its Overweight rating.

Zeta Global (ZETA) — DA Davidson maintained its Buy rating and raised its price target to $38.00 from $36.00.